160 related articles for article (PubMed ID: 8019583)
1. Extension to the use of tolerance intervals for the assessment of individual bioequivalence.
Esinhart JD; Chinchilli VM
J Biopharm Stat; 1994 Mar; 4(1):39-52. PubMed ID: 8019583
[TBL] [Abstract][Full Text] [Related]
2. On TIER method for assessment of individual bioequivalence.
Ju HL
J Biopharm Stat; 1997 Mar; 7(1):63-85. PubMed ID: 9056589
[TBL] [Abstract][Full Text] [Related]
3. A two one-sided tests procedure for assessment of individual bioequivalence.
Liu J; Chow SC
J Biopharm Stat; 1997 Mar; 7(1):49-61. PubMed ID: 9056588
[TBL] [Abstract][Full Text] [Related]
4. On assessment of bioequivalence under a higher-order crossover design.
Chow SC; Liu JP
J Biopharm Stat; 1992; 2(2):239-56. PubMed ID: 1300216
[TBL] [Abstract][Full Text] [Related]
5. Discussion of individual bioequivalence by M.-L. Chen.
Gould AL
J Biopharm Stat; 1997 Mar; 7(1):23-9. PubMed ID: 9056584
[TBL] [Abstract][Full Text] [Related]
6. Individual bioequivalence--a European perspective.
Steinijans VW; Hauschke D
J Biopharm Stat; 1997 Mar; 7(1):31-4. PubMed ID: 9056585
[TBL] [Abstract][Full Text] [Related]
7. Sample size considerations for assessing individual bioequivalence based on the method of tolerance intervals.
Esinhart JD; Chinchilli VM
Int J Clin Pharmacol Ther; 1994 Jan; 32(1):26-32. PubMed ID: 8199749
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence and intrasubject variability.
Liu JP
J Biopharm Stat; 1991; 1(2):205-19. PubMed ID: 1844697
[TBL] [Abstract][Full Text] [Related]
9. Assessment of bioequivalence using a multiplicative model.
Chow SC; Peace KE; Shao J
J Biopharm Stat; 1991; 1(2):193-203. PubMed ID: 1844696
[TBL] [Abstract][Full Text] [Related]
10. Types of bioequivalence and related statistical considerations.
Hauck WW; Anderson S
Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):181-7. PubMed ID: 1592546
[TBL] [Abstract][Full Text] [Related]
11. The assessment of individual and population bioequivalence.
Chinchilli VM
J Biopharm Stat; 1996 Mar; 6(1):1-14. PubMed ID: 8838775
[TBL] [Abstract][Full Text] [Related]
12. A three-step procedure for assessing bioequivalence in the general mixed model framework.
Vuorinen J; Turunen J
Stat Med; 1996 Dec; 15(24):2635-55. PubMed ID: 8981677
[TBL] [Abstract][Full Text] [Related]
13. A method for the evaluation of individual bioequivalence.
Endrenyi L
Int J Clin Pharmacol Ther; 1994 Sep; 32(9):497-508. PubMed ID: 7820334
[TBL] [Abstract][Full Text] [Related]
14. A log-normal model for individual bioequivalence.
Phillips KF
J Biopharm Stat; 1993 Sep; 3(2):185-201. PubMed ID: 8220403
[TBL] [Abstract][Full Text] [Related]
15. Multiple testing for bioequivalence with pharmacokinetic data in 2 x 2 crossover designs.
Chen YI; Huang CS
Stat Med; 2009 Dec; 28(28):3567-79. PubMed ID: 19760611
[TBL] [Abstract][Full Text] [Related]
16. Assessing individual bioequivalence using the structural equation model.
Carrasco JL; Jover L
Stat Med; 2003 Mar; 22(6):901-12. PubMed ID: 12627408
[TBL] [Abstract][Full Text] [Related]
17. The analysis of bioequivalence with respect to TMAX under a 2 x 2 crossover design.
Have TR; Ten Chinchilli VM
J Biopharm Stat; 1995 Jul; 5(2):185-99. PubMed ID: 7581427
[TBL] [Abstract][Full Text] [Related]
18. A comment on so-called individual criteria of bioequivalence.
Wellek S
J Biopharm Stat; 1997 Mar; 7(1):17-21. PubMed ID: 9056583
[TBL] [Abstract][Full Text] [Related]
19. Assessing bioequivalence using genomic data.
Chow SC; Shao J; Li L
J Biopharm Stat; 2004 Nov; 14(4):869-80. PubMed ID: 15587969
[TBL] [Abstract][Full Text] [Related]
20. Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar.
Schall R
Biometrics; 1995 Jun; 51(2):615-26. PubMed ID: 7662849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]